Related Experiment Video

Updated: Aug 17, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Na/K-ATPase, endogenous digitalis like compounds and cancer development -- a hypothesis

Heidrun Weidemann1

  • 1Department of Internal Medicine, Cardiology, The Jewish Hospital, Berlin, Federal Republic of Germany. hweidemann@freenet.de

Frontiers in Bioscience : a Journal and Virtual Library
|June 23, 2005
PubMed

Insights

Altered metabolism of digitalis-like compounds (DLC) and their interaction with Na/K-ATPase may drive cancer development. Research suggests abnormal DLC activity and concentrations are linked to malignancies.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • The Na/K-ATPase is a crucial enzyme regulating ion transport across cell membranes.
  • This enzyme interacts with endogenous digitalis-like compounds (DLC), which are structurally similar to plant and amphibian steroids.
  • DLC have been identified in human tissues, suggesting endogenous roles.

Purpose of the Study:

  • To hypothesize the association between altered endogenous DLC metabolism and Na/K-ATPase interactions in malignancy development.
  • To explore the potential role of DLC in cancer pathogenesis and treatment.

Main Methods:

  • Literature review of studies investigating Na/K-ATPase activity, DLC concentrations, and DLC effects in cancer.
  • Analysis of data from cancer patients and animal models regarding DLC metabolism and Na/K-ATPase sensitivity.

Main Results:

  • Malignant cells exhibit abnormal Na/K-ATPase activity and altered sensitivity to DLC.
  • Cancer patients often display abnormal plasma concentrations of DLC.
  • Studies in immune-compromised mice show aberrant DLC synthesis and release.
  • DLC have demonstrated beneficial effects in preclinical cancer models.

Conclusions:

  • Alterations in endogenous DLC metabolism and their interaction with Na/K-ATPase are proposed as potential contributors to cancer development.
  • These findings suggest DLC may represent a novel therapeutic target in oncology.

More Related Videos

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice08:31

Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice

Published on: June 30, 2021

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...